RICERCA ITALIANA     

Programmi di ricerca simili:

• 1 - RUOLO DEL SEGNALE LIPIDICO NUCLEARE NEL PASSAGGIO G1/S DEL CICLO CELLULARE
• 2 - INTERRELAZIONI TRA LA PERMEABILITÀ IONICA DI MEMBRANA E LO STATO REDOX INTRACELLULARE NEI PROCESSI NEURODEGENERATIVI: AZIONE DEI PEPTIDI AMILOIDI IN CELLULE NEURONALI E GLIALI.
• 3 - Interrelazione tra l'espressione polarizzata del canale CFTR (Cystic Fibrosis Transmembrane Conductance Regulator) e l'organizzazione citoscheletrica e giunzionale in monostrati polarizzati di cellule respiratorie umane.
• 4 - Mitocondri e morte cellulare: identificazione di nuovi bersagli terapeutici
• 5 - Il fattore di trascrizione NF-kB nella regolazione del differenziamento ed apoptosi del sistema immune.
• 6 - EFFETTI MOLECOLARI PLEIOTROPI DELLA INIBIZIONE DELLA PDE5
• 7 - Caratterizzazione molecolare dell'eritropoiesi:analisi post-genomica e funzionale del profilo di espressione proteica
• 8 - Studio del signalling intracellulare e dei microdomini di membrana nel controllo dei processi proliferativi ed antiproliferativi nei tumori ipofisari.
• 9 - ADIPOSITA' E BILANCIO ENERGETICO:FATTORI ENDOCRINI, MECCANISMI CELLULARI ED ASPETTI FISIO-PATOLOGICI
• 10 - Medulloblastoma: studio delle vie molecolari di sviluppo e progressione tumorale allo scopo di identificare approcci terapeutici innovativi

Classificazione scientifico-disciplinare

• Area scientifico disciplinare: Scienze mediche
  • ENDOCRINOLOGIA
  • NEUROLOGIA
  • SCIENZE TECNICHE DI MEDICINA DI LABORATORIO
• Area scientifico disciplinare: Scienze biologiche
  • FISIOLOGIA
  • BIOCHIMICA

Classificazione brevettuale

• CHEMISTRY; METALLURGY
  • BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF (biocides, pest repellants or attractants, or plant growth regulators, containing micro-organisms, viruses, microbial fungi, enzymes, fermentates or substances produced by or extracted from micro-organisms or animal material A01N63/00; food compositions A21, A23; medicinal preparations A61K; chemical aspects of, or use of materials for, bandages, dressings, absorbent pads or surgical articles A61L; fertilisers C05); PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS (preservation of living parts of humans or animals A01N1/02); MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (micro-biological testing media C12Q)
  • ORGANIC CHEMISTRY (such compounds as the oxides, sulfides, or oxysulfides of carbon, cyanogen, phosgene, hydrocyanic acid or salts thereof C01; products obtained from layered base-exchange silicates by ion-exchange with organic compounds such as ammonium, phosphonium or sulfonium compounds or by intercalation of organic compounds C01B33/44; macromolecular compounds C08; dyes C09; fermentation products C12; fermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture C12P; production of organic compounds by electrolysis or electrophoresis C25B3/00, C25B7/00)
    • STEROIDS (Seco-steroids C07C)
• HUMAN NECESSITIES
  • MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES (bringing into special physical form A61J [N: mechanical aspects]; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; compounds per se C01, C07, C08, C12N; soap compositions C11D; micro-organisms per se C12N) [C0203]

Classificazione geografica

• Regione: Toscana

Bibliografia

1) Selkoe DJ (2001) Alzheimer’s disease: genes, proteins, and therapy. Physiol Rev 81:741-66
2) Simons M, Keller P, Dichgans J, et al. (2001) Cholesterol and Alzheimer’s disease: is there a link? Neurology 57:1089-93
3) Zimmermann M, Gardoni F, Di Luca M (2005) Molecular Rationale for the pharmacological treatment of Alzheimer’s Disease. Drugs & Aging 22:27-37
4) Kaether C, Haass C (2004) A lipid boundary separates APP and secretases and limits amyloid beta-peptide generation. J Cell Biol 167:809-12
5) Vetrivel KS, Thinakaran G (2006) Amyloidogenic processing of beta-amyloid precursor protein in intracellular compartments. Neurology 66:69-73
6) Brown DA, London E (2000) Structure and function of sphingolipid- and cholesterol-rich membrane rafts. J Biol Chem 275:17221-4
7) Simons K, Toomre D (2000) Lipid rafts and signaling transduction. Nat Rev Mol Cell Biol 1:31-41
8) Jacobson K, Dietrich C (1999) Looking at lipid rafts? Trends Cell Biol 9:87-91
9) Cary LA, Cooper JA (2000) Molecular switches in lipid rafts. Nature 404:945-7
10) Bodovitz S, Klein WL (1996) Cholesterol modulates alpha secretase cleavage of amyloid precursor protein. J Biol Chem 271:4436-40
11) Petanceska SS, Nagy V, Frail D, et al. (2000) Ovariectomiy and 17beta-estradiol modulate the levels of Alzheimer’s amyloid beta peptides in brain. Neurology 54:2212-7
12) Manthey D, Heck S, Engert S, et al. (2001) Estrogen induces a rapid secretion of amyloid beta precursor protein via the mitogen-activated protein kinase pathway. Eur J Biochem 268:4285-91
13) Goodenough S, Engert S, Behl C (2000) Testosterone stimulates rapid secretory amyloid precursor protein release from rat hypothalamic cells via the activation of the mitogen-activated protein kinase pathway. Neurosci Lett 296:49-52
14) Mattson MP, Cheng B, Davis D, et al. (1992) beta-amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity. J Neurosci 12:379-89
15) Arispe N and Doh M (2002) Plasma membrane cholesterol controls the cytotoxicity of Alzheimer's disease AbetaP (1-40) and (1-42) peptides. FASEB J 16:1526-36
16) Kawahara M, Kurod y, Arispe N, et al. (2000) Alzheimer's beta-amyloid, human islet amylin, and prion protein fragment evoke intracellular free calcium elevations by a common mechanism in a hypothalamic GnRH neuronal cell line. J Biol Chem 275:14077-83
17) Sponne I, Fifre A, Kriem B, et al. (2004) Membrane cholesterol interferes with neuronal apoptosis induced by soluble oligomers but not fibrils of the amyloid-beta peptide. FASEB J 18:836-38
18) Stefani M (2004) Protein misfolding and aggregation: new examples in medicine and biology of the dark side of the protein world. Biochim Biophys Acta 1739:5-25
19) Resnick SM, Henderson VW (2002) Hormone therapy and risk of Alzheimer disease: A critical time. JAMA 288:2170-72
20) Simpkins JW, Yang SH, Wen Y, et al. (2005) Estrogens, progestins, menopause and neurodegeneration: basic and clinical studies. Cell Mol Life Sci 62:271-80
21) Hogervorst E, Williams J, Budge M, et al. (2000) The nature of the effect of female gonadal hormone replacement therapy on cognitive function in post-menopausal women: a meta-analysis. Neuroscience 101:485–512
22) Brinton RD (2004) Impact of estrogen therapy on Alzheimer's disease: a fork in the road?
CNS Drugs 18:405-22
23) Meethal SV, Smith MA, Bowen RL, et al. (2005) The gonadootropin connection in Alzheimer’s disease. Endocrine 26:317-25
24) Bowen RL, Verdile G, Liu T, et al. (2004) Luteinizing hormone, a reproductive regulator that modulates the processing of amyloid-beta precursor protein and amyloid-beta deposition. J Biol Chem 279:20539-45
25) Gregory CW, Bowen RL (2005) Novel therapeutic strategies for Alzheimer's disease based on the forgotten reproductive hormones. 62:313-9
26) Meethal SV, Atwood CS (2005) The role of hypothalamic-pituitary-gonadal hormones in the normal structure and functioning of the brain. Cell Mol Life Sci 62:257-70
27) Atwood CS, Meethal SV, Liu T, et al. (2005) Dysregulation of the hypothalamic-pituitary-gonadal axis with menopause and andropause promotes neurodegenerative senescence. J Neuropathol Exp Neurol 64:93-103
28) Gore AC, Windsor-Engnell BM, Terasawa E (2004) Menopausal increases in pulsatile gonadotropin-releasing hormone release in a nonhuman primate (Macaca mulatta). Endocrinology 145:4653-9
29) Gill S, Sharpless JL, Rado K, et al. (2002) Evidence that GnRH decreases with gonadal steroid feedback but increases with age in postmenopausal women. J Clin Endocrinol Metab 87:2290-6
30) Rance NE, Uswandi SV (1996) Gonadotropin-releasing hormone gene expression is increased in the medial basal hypothalamus of postmenopausal women. J Clin Endocrinol Metab 81:3540-6
31) Jennes L, Eyigor O, Janovick JA, et al. (1997) Brain gonadotropin releasing hormone receptors: localization and regulation. Recent Prog Horm Res 52:475-90
32) Badr M, Marchetti B, Pelletier G (1989) Changes in hippocampal LH-RH receptor density during maturation and aging in the rat. Brain Res Dev Brain Res 45:179-84
33) He D, Funabashi T, Sano A, et al. (1999) Effects of glucose and related substrates on the recovery of the electrical activity of gonadotropin-releasing hormone pulse generator which is decreased by insulin-induced hypoglycemia in the estrogen-primed ovariectomized rat. Brain Res 820:71-6
34) Lu F, Yang JM, Wu JN, et al. (1999) Activation of gonadotropin-releasing hormone receptors produces neuronal excitation in the rat hippocampus.Chin J Physiol 422:67-71
35) Wilson AC, Roche KM, Meethal SV, et al. (2004) Localization of gonadotropin releasing hormone receptor on pyramidal neurons of the human hippocampus. Soc Neurosci Prog Number 902.13
36) Casadesus G, Webber KM, Atwood CS, et al. (2006) Luteinizing hormone modulates cognition and amyloid-beta deposition in Alzheimer APP transgenic mice. Biochim Biophys Acta 1762:447-52
37) Navratil AM, Bliss SP, Berghorn KA, et al. (2003) Constitutive localization of the gonadotropin-releasing hormone (GnRH) receptor to low density membrane microdomains is necessary for GnRH signaling to ERK. J Biol Chem 278:31593-602
38) Benvenuti S, Luciani P, Vannelli GB, et al. (2005) Estrogen and SERMs exert neuroprotective effects and stimulate the expression of seladin-1, a recently discovered anti-apoptotic gene, in human neuroblast long-term cell cultures. J Clin Endocrinol Metab 90:1775-82
39) Greeve I, Hermans-Borgmeyer I, Brellinger C, et al. (2000) The human DIMINUTO/DWARF1 homolog seladin-1/DHCR24 confers resistance to Alzheimer’s disease-associated neurodegeneration and oxidative stress. J Neurosci 20:7345-52
40) Vannelli GB, Ensoli F, Zonefrati R, et al. (1995) Neuroblast long-term cell cultures from human fetal olfactory epithelium respond to odors. J Neurosci 15:4382-94
41) Peri A, Danza G, Serio M (2005) Seladin-1 as a target of estrogen receptor activation in the brain: a new gene for a rather old story? J Endocrinol Invest 28:285-93
42) Waterham HR, Koster J, Romeijn GJ, et al. (2001) Mutations in the 3beta-hydroxysterol Delta-reductase gene cause desmosterolosis, an autosomal recessive disorder of cholesterol biosynthesis. Am J Hum Genet 69:685-94
43) Crameri A, Biondi E, Kuehnle K, et al. (2006) The role of seladin-1/DHCR24 in cholesterol biosynthesis, APP processing and Abeta generation in vivo. EMBO J 25:432-43
44) Rajendran L, Simons K (2005) Lipid rafts and membrane dynamics J Cell Sci 118:1099-102
45) Marquez DC, Chen HW, Curran EM, et al. (2006) Estrogen receptors in membrane lipid rafts and signal transduction in breast cancer. Mol Cell Endocr 246: 91-100
46) Herman GE (2003) Disorders of cholesterol biosynthesis: prototypic metabolic malformation syndromes. Hum Mol Genet. 12:R75-88

Parole Chiave

MALATTIA DI ALZHEIMER, ESTROGENI, GNRH, COLESTEROLO, RAFT LIPIDICI, BETA AMILOIDE, SELADIN-1, DHCR24, NEURONI